Qube Research & Technologies Ltd

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in PLRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,437

-$2,380 QoQ

Shares Held

10,033

-8.5% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 86 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. PLRX ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,437	10,033	-8.5%	Shares	Sole	2026-08-14
2026-03-31	$13,817	10,966	-28.9%	Shares	Sole	2026-05-15
2025-12-31	$18,818	15,425	-68.8%	Shares	Sole	2026-02-17
2025-09-30	$73,282	49,515	-67.4%	Shares	Sole	2025-11-14
2025-06-30	$175,927	151,662	+104.9%	Shares	Sole	2025-08-14
2023-06-30	$1,341,333	74,025	-57.9%	Shares	Sole	2023-08-14
2023-03-31	$4,678,275	175,875	+128.2%	Shares	Sole	2023-05-15
2022-12-31	$1,489,763	77,070	+186.5%	Shares	Sole	2023-02-14
2022-09-30	$561,961	26,901	+99.9%	Shares	Sole	2022-11-14
2022-06-30	$107,806	13,459	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.